Clinical Trial Update: OLE Study With Filgotinib in JIA [Phase 3]

View source ↗

Summary

Phase 3 ongoing trial update for filgotinib in juvenile idiopathic arthritis (JIA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Alfasigma S.p.A. | Conditions: Juvenile Idiopathic Arthritis (JIA) | Phase 3 | Status: RECRUITING